News

Medidur is a tiny, injectable device being studied as a way to deliver fluocinolone acetonide, a corticosteroid, to the retina for up to three years as a treatment

Adventrx plans to further investigate Thiovir efficacy against multiple H5N1 strains of avian influenza in both in vitro and in vivo studies in collaboration. “We are encouraged by

The deal includes Neuromed’s lead compound, NMED-160, which is currently in phase II development for the treatment of pain. Under the terms of the agreement, Neuromed will grant

PTC’s small molecules are designed to inhibit the hepatitis C virus (HCV) internal ribosome entry site (IRES) mediated production of viral proteins. The IRES is highly conserved among

Based on the previous performance of Altropane and Boston’s monitoring of non-blinded data from the approximately 200 patients enrolled in the current trial, the company believes it may

The trial is an open-label, multi-center study designed to examine the safety and efficacy of SNS-595 as a second-line agent in patients with small cell lung cancer who

Patients completing the 24-week Canadian phase III trial, named SPIRIT, were given the opportunity to continue therapy for an additional 36 weeks or to discontinue therapy. Those patients

The primary purpose of the upcoming study is to confirm positive clinical results published in 2002, which demonstrated that Celadrin oral capsules improved range of motion and overall

In a letter to National Institute of Environmental Health Sciences (NIEHS) director Dr David Schwartz, eight Congressional and Senate leaders stated that any relevant studies conducted by the